Septerna: Novo's Investment In Incretin Program Intrigues - One For The Watchlist
If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth?Septerna (NASDAQ: SEPN ) is a San Francisco based biotech that completed its IPO in October 2024, raising ~18 per share. As is typical of most biotech stocks post- ...